Impact of radiation on host immune system in patients treated with chemoradiotherapy and durvalumab consolidation for unresectable locally advanced non-small cell lung cancer.
Frontiers in oncology(2023)
摘要
The inclusion of at least one NITDLN station within the CTV was an independent factor for poorer PFS in the context of CCRT and durvalumab for LA-NSCLC. The optimal sparing of immune structures might help in achieving better synergy between radiotherapy and immunotherapy in this indication.
更多查看译文
关键词
radiotherapy,immunotherapy,non-small cell lung cancer (NSCLC),tumor-draining lymph nodes (TDLN),EDRIC,lymphopenia
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要